Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Most children with a common hemochromatosis genotype had elevated iron levels but no severe symptoms.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

LED light therapy may help hair growth by activating certain cell pathways.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Alefacept showed some effectiveness for alopecia areata but needs more research.

COVID-19 infection may trigger alopecia areata in some patients.

DNA methylation changes are linked to hair growth cycles in goats.

Immune cells affect hair growth and could lead to new hair loss treatments.

IGF-1 affects hair loss and could be a potential treatment.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Gray hair can potentially be reversed, leading to new treatments.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

Different types of inactive melanocyte stem cells exist with unique characteristics and potential to develop into other cells.

Stress-related hair loss was reversed with a special medication.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.